Drug intelligence / Profile preview

dipotassium glycyrrhizinate

Development stage
Unknown
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Topical, Oral, Intravenous
01

Overview

Dipotassium glycyrrhizinate is the dipotassium salt of glycyrrhizic acid, a compound derived from licorice root (Glycyrrhiza glabra). It is widely used for its anti-inflammatory, antioxidant, anti-allergic, and skin-soothing properties. Mechanistically, it inhibits phospholipase A2 and cyclooxygenase activity—key enzymes in inflammatory pathways—and suppresses the formation of prostaglandins. It also inhibits hyaluronidase and reduces the release of pro-inflammatory mediators such as TNF-alpha and NF-κB translocation. Clinically and cosmetically, it is indicated for chronic hepatitis (to reduce liver inflammation), eczema, dermatitis, rosacea (to soothe inflamed skin), gingival inflammation (oral care), burns/wounds healing support, as well as in products targeting hyperpigmentation due to its ability to inhibit tyrosinase activity involved in melanin synthesis. Additionally reported benefits include hepatoprotective effects and potential antitumorigenic activity[1][2][3][5].

Brand names
Neubormitin
Other names
甘草酸二钾dipotassium glycyrrhizateDPGglycyrrhizic acid dipotassium salt
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))COXHYAL (Hyaluronidase family (HYAL))NF-κBPLA2 (Phospholipase A2 group IID)TYR (Tyrosinase)

Beyond the preview

Go deeper on dipotassium glycyrrhizinate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dipotassium glycyrrhizinate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call